Reversal of Neuromuscular Blockade and Perioperative Arrhythmias

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

October 1, 2019

Study Completion Date

November 1, 2019

Conditions
Neuromuscular Blockade
Interventions
DRUG

Neostigmine

50 mcg/kg neostigmine was used under the guidance of TOF monitoring after cessation of anesthesia.

DRUG

Sugammadex

2 mg/kg sugammadex was used under the guidance of TOF monitoring after cessation of anesthesia.

Trial Locations (1)

34214

Istanbul Medipol University, Istanbul

All Listed Sponsors
collaborator

Medipol University

OTHER

lead

Başakşehir Çam & Sakura City Hospital

OTHER_GOV

NCT04720573 - Reversal of Neuromuscular Blockade and Perioperative Arrhythmias | Biotech Hunter | Biotech Hunter